News for Treace Medical Concepts, Inc. (TMCI)

NEW YORK, April 11, 2025 (GLOBE NEWSWIRE) -- Scott Scott Attorneys at Law LLP (”œScott+Scott”), an international shareholder and consumer rights litigation

Truist Financial has revised its price target for Treace Medical (TMCI), lowering it to $8 from the previous $9.50. The firm maintains a Hold rating on the stoc

**media[587778]**

PONTE VEDRA, Fla., March 28, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (”œTreace” or the ”œCompany”) (NasdaqGS: TMCI), a medical technology

**media[579856]**

**media[576511]**

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q4 2024 Earnings Conference Call February 27, 2025 4:30 PM ETCompany ParticipantsVivian Cervantes - Investor...

Revenue (Q4 2024): $68.7 million, a 10.4% increase over Q4 2023.Full Year Revenue (2024): $209.4 million, a 12% increase over 2023.Gross Margin (Q4 2024): 80.7

Feb 27, 2025 / 09:30PM GMTOperator Welcome to the Trece Medical concepts, fourth quarter of 2024 earnings conference call. (Operator Instructions) Please be adv

Treace Medical Concepts (TMCI) delivered earnings and revenue surprises of 66.67% and 0.16%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

On December 31, 2024, ARMISTICE CAPITAL, LLC (Trades, Portfolio) executed a strategic transaction by acquiring an additional 13,000 shares of Treace Medical Con

**media[539787]**

PONTE VEDRA, Fla., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (”œTreace” or the ”œCompany”) (NasdaqGS: TMCI), a medical technology

**media[534568]**

Shares of INNOVATE Corp. VATE rose sharply in today's pre-market trading. INNOVATE announced the FDA approval of MediBeacon’s TGFR System For accurate kidney...

Shares of Versus Systems Inc. VS rose sharply in today's pre-market trading after the company announced expansion into the Brazilian market as part of its strat...

Shares of Versus Systems Inc. VS rose sharply in today's pre-market trading after the company announced expansion into the Brazilian market as part of its strat...

Treace Medical Concepts expects strong Q4 revenue of $68.4-$68.8 million, beating estimates.

PONTE VEDRA, Fla., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (”œTreace” or the ”œCompany”) (NasdaqGS: TMCI), a medical technology